Fri, 11 Feb 2022 | BUSINESS SALE
Guildford-based pharmaceutical firm Ergomed has announced the acquisition of ADAMAS Consulting Group for £25.6 million. The price represents approximately a 14.2x multiple of ADAMAS’ £1.8 million adjusted EBITDA for 2021, generated on revenue of £8.5 million.
Ergomed has said that it expects the acquisition, which reflects an enterprise value of £24.2 million along with £1.4 million in acquired cash, to be immediately earnings enhancing and to generate ongoing synergies and strategic benefits over coming years. A key asset that Ergomed will be acquiring is ADAMAS’ global reach, which will significantly enhance Ergomed’s presence.
Based in Berkshire, ADAMAS provides regulatory compliance and consulting for clients in the global pharmaceutical sector. The company provides a range of quality assurance services and specialises in auditing for pharma manufacturing, clinical trials and pharmacovigilance systems.
It has over 100 active clients and has worked with more than 700 companies in the pharmaceutical industry, including 40 of the 50 largest firms in the global biotech and pharma sectors. Post-acquisition, ADAMAS will continue to operate as an independent consultancy, with its senior executive team remaining in place.
The takeover is in line with Ergomed’s M&A strategy, through which it targets deals that enhance its global presence, broaden its service offering and ensure that quality and compliance remain at the heart of its growth.
The acquisition also reflects a wider boom in professional services M&A, with professional services firms in the pharmaceutical and healthcare sectors having become highly sought-after acquisition targets in recent years, particularly since the start of the COVID-19 pandemic.
Ergomed Executive Chairman Dr Miroslav ReljanoviÄ said: “This value-enhancing acquisition aligns with our disciplined M&A strategy, strengthening our position as a focused premium pharmaceutical services business, whilst further building our Group’s scale in the strategically important US, Europe and APAC regions.”
“With this deal we are addressing the pharmaceutical industry’s ever-growing need for best practice quality assurance due to the increasing complexity of drug development, pharmacovigilance and manufacturing processes and associated regulatory requirements.”
“We look forward to working with Ian and the ADAMAS management team as we invest in and support this business to deliver a broader service offering to clients.”
Find businesses for sale here.
If you are looking for an exit, We can help!
An opportunity has arisen to acquire a well-established and highly profitable aesthetic clinic, nestled in a prestigious area of London. This thriving practice boasts a secure future with over five years remaining on its lease, providing a solid foun...
Established over 10 years with database of over 6000 clients, three storey 1,700 sq.ft high street unit net profit on accounts £150,000 – only trading 5 days a week.
This East Midlands-based company specialises in non-emergency patient transport, transferring NHS patients to and from hospitals, care homes and private properties. The company operates 24 hours a day, 365 days a year, and provides UK-wide coverage.
The business and assets of eyewear and optician chain Ollie ...
Business Sale Report is your complete solution to finding great acquisition opportunities.
Join today to receive:
All this and much more, including the latest M&A news and exclusive resources
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.